StockData
AstraZeneca PLC logo

AstraZeneca PLC (AZN) stock

AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)

Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%

AstraZeneca shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

AstraZeneca's shares outstanding was 1.56B at Jun 30, 2026. For fiscal 2025 it was 1.56B, down 0.1% from the year before. Over ten years it grew 2.1% a year on average. The highest annual figure on record is 1.56B in fiscal 2024.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 20251.56B-0.1%
FY2024Dec 31, 20241.56B+0.1%
FY2023Dec 31, 20231.56B+0.1%
FY2022Dec 31, 20221.56B+9.3%
FY2021Dec 31, 20211.43B+8.7%
FY2020Dec 31, 20201.31B+0.9%
FY2019Dec 31, 20191.30B+2.7%
FY2018Dec 31, 20181.27B0.0%
FY2017Dec 31, 20171.27B+0.1%
FY2016Dec 31, 20161.27B+0.1%
FY2015Dec 31, 20151.26B–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 20261.56B0.0%
Q2 FY2025Jun 30, 20251.56B+18.3%
Q2 FY2024Jun 30, 20241.56B+18.8%
Q2 FY2023Jun 30, 20231.56B+18.9%
Q2 FY2022Jun 30, 20221.56B+23.1%
Q2 FY2021Jun 30, 20211.32B+4.0%
Q2 FY2020Jun 30, 20201.31B–
Q2 FY2019Jun 30, 20191.31B–
Q2 FY2018Jun 30, 20181.27B–
Q2 FY2017Jun 30, 20171.27B–

More AstraZeneca figures

See a number that looks wrong?